Assignee
YUNGJIN PHARMACEUTICAL CO LTD
KR·12 granted patents·5 pending applications·38 citations·filing 1995–2021
Top patents by PatentIndex Score
17 records- 0178US10766882B21,2-naphthoquinone based derivative and method of preparing the sameYUNGJIN PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 8, 2020·2 cites·1 claims
- 0269US9975883B21,2-naphthoquinone based derivative and method of preparing the sameYUNGJIN PHARMACEUTICAL CO LTD·Filed 2014·Granted May 22, 2018·2 cites·9 claims
- 0357US9999646B2Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredientYUNGJIN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jun 19, 2018·0 cites·4 claims
- 0457US9675658B2Method of treating inflammation, allergy and asthma with a purified extract (ATC2) isolated from Pseudolysimachion rotundam var. subintegrum containing abundant amount of active ingredientYUNGJIN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jun 13, 2017·0 cites·4 claims
- 0557US5731007APharmaceutical composition for skin diseasesYUNGJIN PHARMACEUTICAL CO LTD·Filed 1995·Granted Mar 24, 1998·17 cites·5 claims
- 0656US2023158004A1Enteric-coated preparation comprising pirfenidone having improved safety and stability, and method for preparing sameYUNGJIN PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0754US9655871B2Composition comprising a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient or the compounds isolated therefrom, as an active ingredient for treating a chronic obstructive pulmonary disease and the use thereofYUNGJIN PHARMACEUTICAL CO LTD·Filed 2014·Granted May 23, 2017·0 cites·4 claims
- 0854US9592263B2Purified extract (ATC2) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthmaYUNGJIN PHARMACEUTICAL CO LTD·Filed 2013·Granted Mar 14, 2017·0 cites·6 claims
- 0954US6043373AHeterocycle-fused thiazole derivativesYUNGJIN PHARMACEUTICAL CO LTD·Filed 1996·Granted Mar 28, 2000·17 cites·3 claims
- 1051US2023095520A1Pharmaceutical composition for preventing or treating cancer comprising azole derivatives or pharmaceutically acceptable salt thereofYUNGJIN PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1149US10172816B2Method of treating chronic obstructive pulmonary disease (CPD) with verprosideYUNGJIN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 8, 2019·0 cites·2 claims
- 1245US10046019B2Purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthmaYUNGJIN PHARMACEUTICAL CO LTD·Filed 2016·Granted Aug 14, 2018·0 cites·6 claims
- 1344US12110299B2Thiazole derivatives and pharmaceutically acceptable salts thereofYUNGJIN PHARMACEUTICAL CO LTD·Filed 2019·Granted Oct 8, 2024·0 cites·17 claims
- 1441US11684610B2Pharmaceutical composition including 1,2-naphthoquinone derivative compound for prevention or treatment of solid cancers or blood cancersYUNGJIN PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 27, 2023·0 cites·6 claims
- 1535US2017172929A1Pharmaceutical composition containing pregabalin with improved stability and method for preparing sameYUNGJIN PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
- 1633US2018105548A1A novel compound (KS-513) isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereofYUNGJIN PHARMACEUTICAL CO LTD·Filed 2016·Application pending·0 cites
- 1731US2017217982A1Compound isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same for treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereofYUNGJIN PHARMACEUTICAL CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when YUNGJIN PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →